A material equivalent of a biosynapse is the key to neuromorphic architecture. Here we report a self-forming labyrinthine Ag nanostructure activated with a few pulses of 0.5 V, width and interval set at 50 ms, at current compliance () of 400 nA, serving as the active material for a highly stable device with programmable volatility. Both the conductance () and its retention time () in the potentiated state are found to vary linearly with the pulse number for pulses of positive and negative polarities, with the nonlinearity factors being noticeably small, ∼0.03 for during potentiation and ∼0.08 during depression. This was tested for over 200 days, and the results were highly reproducible. Relying on the high linearity, arithmetic operations involving counting of positive and negative integers were realized using pulses of both polarities, often by mixing them in the feeding sequence. The observed outcomes based on and independently from are highly accurate, with deviations being typically less than ∼1.5% from the expected results. Notably, the way the pulse polarities are mixed is found to have an influence, with random sequences producing relatively larger deviations in integer estimation. However, deviations decreased with higher values, which promoted stronger filament formation in the percolation networks. Besides, the and values were found to vary with the pulse amplitude as well, which enabled the calculation of the area under a curve. Further, the device exhibited a simulation-based image classification accuracy of 94.95%, close to the ideal value (96.05%). Simulations utilizing the finite element method have showcased the uniqueness of the labyrinthine morphology, giving rise to field intensification along potential percolative paths.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsami.4c19473DOI Listing

Publication Analysis

Top Keywords

positive negative
8
self-formed nanostructure
4
nanostructure based
4
based neuromorphic
4
neuromorphic device
4
device performing
4
performing arithmetic
4
arithmetic computation
4
computation area
4
area integration
4

Similar Publications

Background: Pharmacoepidemiologic studies assessing drug effectiveness for Alzheimer's disease and related dementias (ADRD) are increasingly popular given the critical need for effective therapies for ADRD. To meet the urgent need for robust dementia ascertainment from real-world data, we aimed to develop a novel algorithm for identifying incident and prevalent dementia in claims.

Method: We developed algorithm candidates by different timing/frequency of dementia diagnosis/treatment to identify dementia from inpatient/outpatient/prescription claims for 6,515 and 3,997 participants from Visits 5 (2011-2013; mean age 75.

View Article and Find Full Text PDF

Background: Memory is influenced by epigenetic mechanisms that regulate gene expression. Histone acetyltransferases (HATs), and histone deacetylases (HDACs), are two competitive enzymes regulating histone acetylation. Histone acetylation is reduced in Alzheimer's disease (AD) brains, and evidence has shown a synergistic regulation of HDACs and HATs activities.

View Article and Find Full Text PDF

Background: SHIP1 is a phosphatidyl inositol phosphatase encoded by INPP5D, which has been identified as a risk gene for Alzheimer's disease (AD). SHIP1 is expressed in microglia, the resident macrophage in brain. It is a complex, multidomain protein that acts as a negative regulator downstream from TREM2.

View Article and Find Full Text PDF

Background: Positive findings from testing therapeutics in AD animal models are often not translated to effective treatments due to the poor methodological rigor and inadequate reporting practices of therapeutic efficacy studies. The Alzheimer's Disease Preclinical Efficacy Database (AlzPED), developed by the NIA, is a searchable and publicly available knowledgebase that prioritizes and promotes the use of rigorous methodology to ameliorate this translation gap. Through a checklist of experimental design elements - the Rigor Report Card - AlzPED highlights reporting recommendations and standards while providing a practical tool to help plan rigorous therapeutic studies in animals.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

School of Medicine, Johns Hopkins University, and Johns Hopkins Bayview Medical Center, Baltimore, MD, USA.

Background: Agitation is a common and disabling symptom of Alzheimer's dementia (AD). Pharmacological treatments are recommended if agitation is not responsive to psychosocial intervention. Citalopram was effective in treating agitation in AD but was associated with cognitive and cardiac risks linked to its R- but not S-enantiomer.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!